Anchor Glass’s Senior Secured Loan Facilities
February 21, 2017
Cravath represented Credit Suisse AG in connection with the arrangement of a $650 million senior secured first lien term loan facility and a $150 million senior secured second lien term loan facility, and UBS AG in connection with the arrangement of a $120 million senior secured ABL facility. In each case, the loans were made available to an affiliate of CVC Capital Partners Advisory (U.S.), Inc. and BA Glass B.V. to finance their acquisition of the shares of Glass Container Holdings, Inc. and for general corporate purposes. Glass Container Holdings, Inc. is the parent company of Anchor Glass Container Corporation, a leading manufacturer of glass packaging for beer, liquor, food, beverage, ready‑to‑drink and consumer end‑markets. The transactions closed on December 7, 2016.
The Cravath team included partners Paul H. Zumbro and Craig F. Arcella, senior attorney Sarah F. Rosen and associates Isaac C. Beerman, Bethany A. Pfalzgraf, Samuel P. Niles, Noah X. DeBlasi and Shakera M. Thompson on banking matters; practice area attorney Janet L. Lewis on real estate matters; partner Matthew Morreale on environmental matters; and partner Eric W. Hilfers on executive compensation and benefits matters. Anthony J. Ramirez and Nathan H. Trunnell also worked on banking matters and Christopher C. Gonnella also worked on executive compensation and benefits matters.
Related Practices & Industries
People
- Photo
-
-
J.D., 1997, Columbia Law SchoolHarlan Fiske Stone Scholar
-
B.A., 1992, Yale CollegeDistinction in Major, cum laude
- New York
Education
Admitted In
- Photo
-
-
J.D., 1998, Columbia Law SchoolHarlan Fiske Stone Scholar
-
B.A., 1995, Duke University
- New York
Education
Admitted In
-
J.D., 2005, Columbia Law SchoolHarlan Fiske Stone Scholar
-
B.A., 2002, New York Universitymagna cum laude
- New York
Education
Admitted In
- Photo
-
-
J.D., 1997, Columbia Law SchoolHarlan Fiske Stone Scholar
-
M.S., 1994, University of Pennsylvania
-
B.A., 1990, University of Pennsylvania
-
B.A.S., 1990, University of Pennsylvania
- New York
Education
Admitted In
- Photo
-
-
J.D., 1998, University of Chicago Law Schoolwith Honors
-
A.B., 1995, Princeton University
- New York
Education
Admitted In
Related News & Insights
Deals & Cases
July 06, 2026
UVEX’s Upsize and Repricing of its Term Loan Facility
Cravath represented the agent, mandated lead arrangers, and lenders in connection with the repricing of UVEX GROUP GmbH’s €400 million term loan facility and €50 million term loan add-on. UVEX GROUP GmbH is a portfolio company of Warburg Pincus. The transaction closed on June 19, 2026.
Deals & Cases
April 06, 2026
Versigent’s $1.35 Billion Credit Facilities and $1.6 Billion High‑Yield Senior Notes Offering in Connection with Aptiv PLC’s Spin‑Off of Versigent
Cravath represented the administrative agent, joint lead arrangers and joint bookrunners in connection with $1.35 billion of credit facilities made available to subsidiaries of Versigent Limited, a global leader in the design, development and manufacture of low voltage and high voltage electrical architectures and the holding company for Aptiv PLC’s Electrical Distribution Systems segment, which Aptiv PLC spun off into a separate, independent, publicly traded company. The proceeds were used to partially finance the spin‑off. The credit facilities consisted of a $500 million term loan facility and an $850 million revolving credit facility. The transaction closed on November 26, 2025.
Deals & Cases
February 20, 2026
First Solar’s $1.5 Billion Revolving Credit Facility
Cravath represented First Solar, Inc. in connection with its $1.5 billion revolving credit facility. First Solar is America’s leading photovoltaic solar technology and manufacturing company, and the only US‑headquartered company among the world’s largest solar manufacturers. The transaction closed on February 13, 2026.
Deals & Cases
January 08, 2026
Genmab’s $3.5 Billion of Credit Facilities and Offering of $1.5 Billion Senior Secured Notes and $1 Billion Senior Unsecured Notes in Connection with its Acquisition of Merus
Cravath represented the administrative agent, joint lead arrangers and joint bookrunners in connection with $3.5 billion of credit facilities made available to Genmab, a leading international biotechnology company, and one of its wholly‑owned subsidiaries, Genmab Finance LLC, as part of the financing transactions undertaken in connection with its acquisition of Merus N.V., a leading oncology company developing innovative antibody therapeutics. The credit facilities consisted of a $2 billion term loan “B” facility, a $1 billion term loan “A” facility and a $500 million revolving credit facility. The transaction closed on December 12, 2025.
